55 related articles for article (PubMed ID: 27828631)
1. Response to Venables and Levell.
Ferguson J; Eleftheriadou V; Nesnas J
J Invest Dermatol; 2024 Feb; 144(2):415-416. PubMed ID: 37977499
[No Abstract] [Full Text] [Related]
2. Selective adhesion inhibition and hyaluronan envelope reduction of dermal tumor cells by cold plasma-activated medium.
Golz AC; Bergemann C; Hildebrandt F; Emmert S; Nebe B; Rebl H
Cell Adh Migr; 2023 Dec; 17(1):1-19. PubMed ID: 37743639
[TBL] [Abstract][Full Text] [Related]
3. Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy.
Kinaneh S; Khamaysi I; Karram T; Hamoud S
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34132790
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases.
Bhattacharjee O; Ayyangar U; Kurbet AS; Ashok D; Raghavan S
Front Cell Dev Biol; 2019; 7():68. PubMed ID: 31134198
[TBL] [Abstract][Full Text] [Related]
5. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
6. Heparanase: Historical Aspects and Future Perspectives.
Khanna M; Parish CR
Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
[TBL] [Abstract][Full Text] [Related]
7. Expression of heparanase in basal cell carcinoma and squamous cell carcinoma.
Pinhal MA; Almeida MC; Costa AS; Theodoro TR; Serrano RL; Machado CD
An Bras Dermatol; 2016; 91(5):595-600. PubMed ID: 27828631
[TBL] [Abstract][Full Text] [Related]
8. Heparanase expression and glycosaminoglycans profile in renal cell carcinoma.
Batista LT; Matos LL; Machado LR; Suarez ER; Theodoro TR; Martins JR; Nader HB; Pompeo AC; Pinhal MA
Int J Urol; 2012 Nov; 19(11):1036-40. PubMed ID: 22738382
[TBL] [Abstract][Full Text] [Related]
9. Heparanase and tumor invasion patterns in human oral squamous cell carcinoma xenografts.
Kurokawa H; Katsube K; Podyma KA; Ikuta M; Iseki H; Nakajima M; Akashi T; Omura K; Takagi M; Yanagishita M
Cancer Sci; 2003 Mar; 94(3):277-85. PubMed ID: 12824922
[TBL] [Abstract][Full Text] [Related]
10. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of glycosaminoglycans and heparanase in placentas of women with preeclampsia.
Famá EA; Souza RS; Melo CM; Melo Pompei L; Pinhal MA
Clin Chim Acta; 2014 Nov; 437():155-60. PubMed ID: 25083812
[TBL] [Abstract][Full Text] [Related]
12. Expression of heparanase in oral cancer cell lines and oral cancer tissues.
Ikuta M; Podyma KA; Maruyama K; Enomoto S; Yanagishita M
Oral Oncol; 2001 Feb; 37(2):177-84. PubMed ID: 11167146
[TBL] [Abstract][Full Text] [Related]
13. Sequence analysis and domain motifs in the porcine skin decorin glycosaminoglycan chain.
Zhao X; Yang B; Solakyildirim K; Joo EJ; Toida T; Higashi K; Linhardt RJ; Li L
J Biol Chem; 2013 Mar; 288(13):9226-37. PubMed ID: 23423381
[TBL] [Abstract][Full Text] [Related]
14. Iduronic acid in chondroitin/dermatan sulfate: biosynthesis and biological function.
Malmström A; Bartolini B; Thelin MA; Pacheco B; Maccarana M
J Histochem Cytochem; 2012 Dec; 60(12):916-25. PubMed ID: 22899863
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
